Jefferies on Compass Pathways (CMPS): 'We remain 75-85%+ confident the FDA approves COMP360 (oral psilocybin) around YE:26/early 2027'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. GOOG
7. CSX
8. KNX
9. IBM
10. LVS

Go back to Jefferies on Compass Pathways (CMPS): 'We remain 75-85%+ confident the FDA approves COMP360 (oral psilocybin) around YE:26/early 2027'
(NASDAQ: CMPS) Delayed: 11.64 -0.29 (2.43%)
Previous Close $11.93    52 Week High $ 
Open $11.80    52 Week Low $ 
Day High $11.95    P/E N/A 
Day Low $11.61    EPS $ 
Volume 1,163,933